Relaxin augments BMP-2-induced osteoblast differentiation and bone formation

Journal of Bone and Mineral Research

Volumn 29, Issue 7, 2014, Pages 1586-1596

  Moon, Jung Sun ^a   Kim, Sun Hun ^a   Oh, Sin Hye ^a   Jeong, Yong Wook ^b   Kang, Jee Hae ^a   Park, Jong Chun ^b   Son, Hye Ju ^a   Bae, Suk ^a   Park, Byung Il ^a   Kim, Min Seok ^a   Koh, Jeong Tae ^a   Ko, Hyun Mi ^b  

^a Chonnam National University   (South Korea)

^b Seonam University   (South Korea)

Author keywords

BMP; BONE; RELAXIN; RXFP

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CELL PROTEIN; COLLAGEN TYPE 1; HORMONE RECEPTOR; OSTEOCALCIN; RELAXIN; RXFP 1 RECEPTOR; SMAD PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; LGR7 PROTEIN, MOUSE; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BINDING; RUNX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; PHOSPHORYLATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; MAP KINASE KINASE KINASES; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RELAXIN; SMAD PROTEINS;

EID: 84903273784     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2197     Document Type: Article

References (49)

1. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH., Bone remodelling at a glance. J Cell Sci. 2011; 124 (Pt 7): 991-8.
2. Chau JF, Leong WF, Li B., Signaling pathways governing osteoblast proliferation, differentiation and function. Histol Histopathol. 2009; 24 (12): 1593-606.
3. Phan TC, Xu J, Zheng MH., Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol. 2004; 19 (4): 1325-44.
4. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007; 131 (2): 324-36.
5. da Silva Meirelles L, Chagastelles PC, Nardi NB., Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119 (Pt 11): 2204-13.
6. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7 (2): 211-28.
7. Amoh Y, Li L, Campillo R, et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A. 2005; 102 (49): 17734-8.
8. Prockop DJ., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276 (5309): 71-4.
9. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284 (5411): 143-7.
10. Aubin JE., Advances in the osteoblast lineage. Biochem Cell Biol. 1998; 76 (6): 899-910.
11. Deng ZL, Sharff KA, Tang N, et al. Regulation of osteogenic differentiation during skeletal development. Front Bioscience. 2008; 13: 2001-21.
12. Huang W, Yang S, Shao J., Li YP. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Bioscience. 2007; 12: 3068-92.
13. Yu B, Zhao X, Yang C, et al. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling. J Bone Miner Res. 2012; 27 (9): 2001-14.
14. Gazzerro E, Canalis E., Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord. 2006; 7 (1-2): 51-65.
15. Tsuji K, Bandyopadhyay A, Harfe BD, et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006; 38 (12): 1424-9.
16. Huang Z, Ren PG, Ma T, Smith RL, Goodman SB., Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine. 2010; 51 (3): 305-10.
17. Chen G, Deng C, Li YP., TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012; 8 (2): 272-88.
18. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, Tabin CJ., Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2006; 2 (12): e216.
19. Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007; 25 (5): 665-77.
20. Cao X, Chen D., The BMP signaling and in vivo bone formation. Gene. 2005; 357 (1): 1-8.
21. Derynck R, Zhang YE., Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425 (6958): 577-84.
22. Winnier G, Blessing M, Labosky PA, Hogan BL., Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995; 9 (17): 2105-16.
23. Miyazono K, Maeda S, Imamura T., Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene. 2004; 23 (24): 4232-7.
24. Wang X, Goh CH., Li B. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology. 2007; 148 (4): 1629-37.
25. Zhang YW, Yasui N, Ito K, et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation,Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S.A. 2000; 97 (19): 10549-54.
26. Ulsamer A, Ortuno MJ, Ruiz S, et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem. 2008; 283 (7): 3816-26.
27. Moustakas A, Heldin CH., Non-Smad TGF-beta signals. J Cell Sci. 2005; 118 (Pt 16): 3573-84.
28. Gallea S, Lallemand F, Atfi A, et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone. 2001; 28 (5): 491-8.
29. Suzawa M, Tamura Y, Fukumoto S, et al. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation. J Bone Miner Res. 2002; 17 (2): 240-8.
30. Kozawa O, Hatakeyama D, Uematsu T., Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. J Cell Biochem. 2002; 84 (3): 583-9.
31. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J., Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res. 2003; 18 (11): 2060-8.
32. Lee KS, Hong SH, Bae SC., Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene. 2002; 21 (47): 7156-63.
33. Lee CH, Huang YL, Liao JF, Chiou WF., Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix. Eur J Pharmacol. 2011; 668 (3): 383-9.
34. Zuzarte-Luis V, Montero JA, Rodriguez-Leon J, Merino R, Rodriguez-Rey JC, Hurle JM., A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol. 2004; 272 (1): 39-52.
35. Sherwood OD., Relaxin's physiological roles and other diverse actions. Endocr Rev. 2004; 25 (2): 205-34.
36. Samuel CS, Lekgabe ED, Mookerjee I., The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease. Adv Exp Med Bio. 2007; 612: 88-103.
37. Silvertown JD, Summerlee AJ, Klonisch T., Relaxin-like peptides in cancer. Int J Cancer. 2003; 107 (4): 513-9.
38. Stewart DR, Sherick P, Kramer S, Breining P., Use of relaxin in orthodontics. Ann N Y Acad Sci. 2005; 1041: 379-87.
39. Bennett RG., Relaxin and its role in the development and treatment of fibrosis. Transl Res. 2009; 154 (1): 1-6.
40. Madan MS, Liu ZJ, Gu GM, King GJ., Effects of human relaxin on orthodontic tooth movement and periodontal ligaments in rats. Am J Orthod Dentofacial Orthop. 2007; 131 (1): 8e 1-10.
41. Ferlin A, Pepe A, Facciolli A, Gianesello L, Foresta C., Relaxin stimulates osteoclast differentiation and activation. Bone. 2010; 46 (2): 504-13.
42. Ferlin A, Pepe A, Gianesello L, et al. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Mineral Res. 2008; 23 (5): 683-93.
43. Manolagas SC, Burton DW, Deftos LJ., 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem. 1981; 256 (14): 7115-7.
44. Greenblatt MB, Shim JH, Glimcher LH., TAK1 mediates BMP signaling in cartilage. Ann N Y Acad Sci. 2010; 1192: 385-90.
45. Yang SY, Ko HM, Kang JH, et al. Relaxin is up-regulated in the rat ovary by orthodontic tooth movement. Eur J Oral Sci. 2011; 119 (2): 115-20.
46. Shim JH, Greenblatt MB, Xie M, et al. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO.J. 2009; 28 (14): 2028-41.
47. Ge C, Yang Q, Zjao G, Yu H, Kirkwood KL, Franceschi RT., Interactions between extracellular signal-regulated kinase 1/2 and p38 map kinase pathways in the control of Runx 2 phosphorylation and transcriptional activity. J Bone Mineral Res. 2012; 27 (3): 538-51.
48. Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T., Regulation of bone and cartilage development by network between BMP signaling and transcription factors. J Biochem. 2012; 151 (3): 247-54.
49. Ryoo HM, Lee MH, Kim YJ., Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene. 2006; 366 (1): 51-7.